Biodexa Pharmaceuticals Plc (BDRX)
1.245
-0.08
(-5.68%)
USD |
NASDAQ |
May 02, 16:00
1.20
-0.04
(-3.61%)
After-Hours: 07:35
Biodexa Pharmaceuticals Price to Book Value: 0.9161 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 0.9161 |
| May 01, 2024 | 0.9713 |
| April 30, 2024 | 1.111 |
| April 29, 2024 | 0.9639 |
| April 26, 2024 | 0.9566 |
| April 25, 2024 | 0.5333 |
| April 24, 2024 | 0.5518 |
| April 23, 2024 | 0.5946 |
| April 22, 2024 | 0.5629 |
| April 19, 2024 | 0.5533 |
| April 18, 2024 | 0.6034 |
| April 17, 2024 | 0.6258 |
| April 16, 2024 | 0.6332 |
| April 15, 2024 | 0.6063 |
| April 12, 2024 | 0.6748 |
| April 11, 2024 | 0.7077 |
| April 10, 2024 | 0.714 |
| April 09, 2024 | 0.7285 |
| April 08, 2024 | 0.7579 |
| April 05, 2024 | 0.7873 |
| April 04, 2024 | 0.8536 |
| April 03, 2024 | 0.8094 |
| April 02, 2024 | 1.001 |
| April 01, 2024 | 1.074 |
| March 28, 2024 | 1.155 |
| Date | Value |
|---|---|
| March 27, 2024 | 0.6125 |
| March 26, 2024 | 0.5714 |
| March 25, 2024 | 0.6988 |
| March 22, 2024 | 0.7487 |
| March 21, 2024 | 0.7554 |
| March 20, 2024 | 0.7487 |
| March 19, 2024 | 0.7346 |
| March 18, 2024 | 0.8129 |
| March 15, 2024 | 0.8343 |
| March 14, 2024 | 0.8058 |
| March 13, 2024 | 0.9056 |
| March 12, 2024 | 0.9056 |
| March 11, 2024 | 0.9341 |
| March 08, 2024 | 0.927 |
| March 07, 2024 | 0.9341 |
| March 06, 2024 | 0.9199 |
| March 05, 2024 | 0.9128 |
| March 04, 2024 | 0.927 |
| March 01, 2024 | 0.9698 |
| February 29, 2024 | 0.6338 |
| February 28, 2024 | 0.6587 |
| February 27, 2024 | 0.6887 |
| February 26, 2024 | 0.6937 |
| February 23, 2024 | 0.7436 |
| February 22, 2024 | 0.7685 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1769
Minimum
Mar 31 2023
7.768
Maximum
Jul 09 2021
1.921
Average
0.9681
Median
Oct 07 2019
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 7.434 |
| NuCana PLC | 0.4421 |
| Autolus Therapeutics PLC | 9.805 |
| Mereo BioPharma Group PLC | 8.632 |
| Bicycle Therapeutics PLC | 2.521 |
Price to Book Value Related Metrics
| PS Ratio | 3.905 |
| Price | 1.245 |
| Earnings Yield | -32.29K% |
| Market Cap | 5.459M |